Dragon Pharmaceuticals Announces Completion of Private Placement
Dragon Pharmaceuticals Inc. is pleased to announce the completion of the private placement of 2,000,000 common shares at US$0.50 per share. The proceeds will be used to fund the on-going development of the Company’s biotech projects in China.
The working capital of the Company currently stands at approximately US$1.4 million. The Company has invested approximately US$550,000 to date on drug licenses and other assets in China.
At a Board of Directors Meeting held on December 16, 1998, the Board appointed Dr. Longbin Liu as President and Mr. Shaun Maskerine as Secretary of the Company.
Dragon Pharmaceuticals Inc. is a biopharmaceutical company with the vision to become a leading biotechnology company in China through research, development, production, and marketing of previously commercialized bio-drugs.
2091 total views, 3 today
